A. C. Chiang
0000-0001-6084-1360
Publication & Citation Trends
Publications
0 total
Abstract CT215: Efficacy and safety of adjuvant (adj) atezolizumab (atezo) from the Phase 2 LCMC3 study
Cited by 0
Semantic Scholar
First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in patients with small cell lung cancer.
Cited by 14
Semantic Scholar
145MO Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study OA
Cited by 4
Semantic Scholar
What Is New in Small Cell Lung Cancer.
Cited by 6
Semantic Scholar
Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer.
Cited by 1
Semantic Scholar
The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.
Cited by 0
Semantic Scholar
Nivolumab and ipilimumab in advanced non small cell lung cancer previously treated with PD1 axis inhibition.
Cited by 1
Semantic Scholar
Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort
Cited by 2
Semantic Scholar
Research Topics
Photorefractive and Nonlinear Optics
(34)
Advanced Fiber Laser Technologies
(29)
Solid State Laser Technologies
(19)
Photonic and Optical Devices
(18)
Terahertz technology and applications
(7)
Affiliations
National Tsing Hua University
Tsinghua University